Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (21-30 of 503) with videos related to

Pageof 51
Sort By:
Haematologica|October 20, 2018
Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesisPhuong M Le, Michael Andreeff, Venkata Lokesh Battula
Cancer Treatment and Research|March 23, 2010
Apoptosis in leukemias: regulation and therapeutic targetingIsmael Samudio, Marina Konopleva, Bing Carter, et al.
Cytotherapy|October 1, 2016
EditorialC Russell Y Cruz, Michael Andreeff, John Barrett
PPAR Research|June 12, 2012
Effects of PPARγ Ligands on LeukemiaYoko Tabe, Marina Konopleva, Michael Andreeff, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 28, 2009
Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approachesMarina Konopleva, Yoko Tabe, Zhihong Zeng, et al.
Molecular Cancer Therapeutics|August 26, 2010
The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemiasKensuke Kojima, Jared K Burks, Janine Arts, et al.
Annals of the New York Academy of Sciences|October 1, 2021
Ganglioside GD2: a novel therapeutic target in triple-negative breast cancerClaire Shao, Vivek Anand, Michael Andreeff, et al.
Cells|May 16, 2023
Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and LeukemiaHiroki Akiyama, Bing Z Carter, Michael Andreeff, et al.
Cancer Science|April 24, 2009
Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AMLKensuke Kojima, Masaya Shimanuki, Masato Shikami, et al.
Molecular Cancer Therapeutics|April 22, 2010
1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53Thelma Thompson, Michael Andreeff, George P Studzinski, et al.
Pageof 51

Showing results (21-30 of 503) with videos related to

Sort By:
Pageof 51
Haematologica|October 20, 2018
Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesisPhuong M Le, Michael Andreeff, Venkata Lokesh Battula
Cancer Treatment and Research|March 23, 2010
Apoptosis in leukemias: regulation and therapeutic targetingIsmael Samudio, Marina Konopleva, Bing Carter, et al.
Cytotherapy|October 1, 2016
EditorialC Russell Y Cruz, Michael Andreeff, John Barrett
PPAR Research|June 12, 2012
Effects of PPARγ Ligands on LeukemiaYoko Tabe, Marina Konopleva, Michael Andreeff, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 28, 2009
Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approachesMarina Konopleva, Yoko Tabe, Zhihong Zeng, et al.
Molecular Cancer Therapeutics|August 26, 2010
The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemiasKensuke Kojima, Jared K Burks, Janine Arts, et al.
Annals of the New York Academy of Sciences|October 1, 2021
Ganglioside GD2: a novel therapeutic target in triple-negative breast cancerClaire Shao, Vivek Anand, Michael Andreeff, et al.
Cells|May 16, 2023
Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and LeukemiaHiroki Akiyama, Bing Z Carter, Michael Andreeff, et al.
Cancer Science|April 24, 2009
Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AMLKensuke Kojima, Masaya Shimanuki, Masato Shikami, et al.
Molecular Cancer Therapeutics|April 22, 2010
1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53Thelma Thompson, Michael Andreeff, George P Studzinski, et al.
Pageof 51